Premenopausal women would benefit from a significantly more accurate diagnostic pathway for ovarian cancer, as a new study finds that an advanced ultrasound test, IOTA ADNEX, identified 9 out of 10 ...
A new ovarian cancer surveillance test is now being offered to women with an inherited risk of the disease, marking a significant development in care. University College London Hospitals NHS ...
A new blood test pioneered by diagnostics company AOA Dx (AOA) can detect ovarian cancer in symptomatic women with high accuracy, a study by researchers from the Universities of Manchester and ...
InterVenn Biosciences, a life sciences company unlocking the value of glycoproteomics for the development of transformational healthcare solutions, and Aranscia, a global provider of award-winning ...
Screening tests check for a condition, like cancer, in people who don’t have any signs or symptoms. There aren’t any standard screening tests for ovarian cancer if you’re at average risk. The best ...
Follow this author to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Patient sitting on treatment couch Personalized Content Follow this author ...
June 14, 2010 — The US Food and Drug Administration (FDA) has cleared a chemiluminescent microparticle immunoassay (Architect human epididymis protein 4 [HE4] assay; Abbott Diagnostics) for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results